1
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
Condition(s):Glioma; Glioblastoma MultiformeLast Updated:August 25, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Glioma; Glioblastoma MultiformeLast Updated:August 25, 2023Not yet recruiting
Condition(s):Oropharyngeal Dysplasia; Oral Cavity Dysplasia; Oral Carcinoma in SituLast Updated:June 8, 2023Recruiting
Condition(s):Head and Neck Cancer; Squamous Cell Carcinoma of Oral Cavity; Squamous Cell Carcinoma of the OropharynxLast Updated:August 2, 2023Recruiting
Condition(s):Glioblastoma; Glioblastoma MultiformeLast Updated:September 22, 2022Available
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.